In a pilot trial evaluating 104 amnestic MCI and early-stage AD patients, 20 IU and 40 IU doses of intranasal insulin improved Alzheimers Disease Assessment Scale-Cognitive subscale (ADAS-Cog 12) scores compared to placebo-treated patients, with improvements in delayed recall observed 2 months following cessation of treatment in the 20 IU group
During your consultation, we evaluate your BMI and weight history, blood pressure and metabolic risk, current medications, and safety factors like thyroid history and contraindications
F., Smith, E
This weight gain is often attributed to aging in general as well as to hormonal changes
Discover how IV vitamin therapy works, its benefits for energy, hydration, and immunity, and what to expect during treatment
The interim analysis for these findings included 800 participants, who were mostly white adults evenly split between males and females, with an average age of 56